Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in High Frequency Migraine
NCT04578782Phase 2Completed
- Sponsor
- IRCCS Mondino Foundation
- Start
- Mar 2018
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in migraine, sponsored by IRCCS Mondino Foundation. Started Mar 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04578782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04578782.